Thoracic Endovascular Aortic Repair (Tevar) Has Revolutionized The Treatment Of Acute Type B Aortic Dissection (Atbad). Prior To Endovascular Therapy, Patients Would Require Either High-Risk, Emergent Open Descending Thoracic Aortic Replacement For The Treatment Of Rupture, Or Revascularization Of An Ischemic Vascular Bed Via Peripheral Bypass Without Treatment Of The Central Aortic Pathology. Over The Past Two Decades, Tevar Has Become The Primary Therapy For Complicated Atbad And There Is Accumulating Data Suggesting That It Should Replace Optimal Medical Therapy (Omt) As Primary Therapy For Uncomplicated Atbad. In This Brief Article We Will Summarize The Current Data Regarding Endovascular Therapy For Atbad
CITATION STYLE
Leshnower, B. G. (2021). Complicated and uncomplicated acute type B aortic dissection: is an endovascular solution the “Holy Grail”? Annals of Cardiothoracic Surgery, 10(6), 784–786. https://doi.org/10.21037/acs-2021-taes-22
Mendeley helps you to discover research relevant for your work.